Startup | February 18, 2022
Evonik invests in start-up to improve patient recovery after open-chest surgery
Evonik invests in start-up to improve patient recovery after open-chest surgery
Evonik invests in start-up to improve patient recovery after open-chest surgery
The speakers for the e-conference are: Dr. Mukund Chorgade, President/CSO, THINQ Pharma; Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance; Jayaseelan J., National Vice President (Industry Division), Indian Pharmaceutical Association; Spandan Mishra who is Director- Sales, Customer Service & Logistics for Evonik India, Nepal & Sri Lanka region; Dr. Kommu Nagaiah, Chief Scientist & Head, CSIR-IICT; Govind K. Jaju, Partner, Suingora Consulting; nd Pravin Prashant, Executive Editor, Indian Pharma Post & Editor, Indian Chemical News.
It will open new frontier for south-to-south collaboration and innovation transfer
Key takeaways of recent quarter & conference call highlights
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
A National Tele Mental Health Programme is being launched to address mental health issues. We spoke to healthcare industry leaders who shared their outlook
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
Subscribe To Our Newsletter & Stay Updated
